Susan Hubbard | EVP, Public Affairs & IR |
Michael Morrissey | CEO, President & Director |
Christopher Senner | EVP & CFO |
Patrick Haley | EVP, Commercial |
Vicki Goodman | EVP, Product Development & Medical Affairs and Chief Medical Officer |
Peter Lamb | EVP, Scientific Strategy & Chief Scientific Officer |
Jason Gerberry | Bank of America Merrill Lynch |
Michael Schmidt | Guggenheim Securities |
Andy Hsieh | William Blair & Company |
Peter Lawson | Barclays Bank |
Jay Olson | Oppenheimer |
Etzer Darout | BMO Capital Markets |
Yaron Werber | Cowen and Company |
Good day, ladies and gentlemen, and welcome to the Exelixis Second Quarter 2022 Financial Results Conference Call. My name is Sarah, and I'll be your operator for today.
As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to your host for today, Ms. Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations.